Glycopeptide Resistance among Coagulase‐Negative Staphylococci that Cause Bacteremia: Epidemiological and Clinical Findings from a Case‐Control Study
Open Access
- 15 November 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (10) , 1628-1635
- https://doi.org/10.1086/323676
Abstract
A 1-year prospective case-control study (ratio of control patients to case patients, 3 : 1) was performed to assess the incidence, risk factors, andKeywords
This publication has 30 references indexed in Scilit:
- LinezolidDrugs, 2001
- Bacteremia Caused by Staphylococci with Inducible Vancomycin HeteroresistanceClinical Infectious Diseases, 1999
- Current and future management of infections due to methicillin-resistant staphylococci infections: the role of quinupristin/dalfopristinJournal of Antimicrobial Chemotherapy, 1999
- Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptidesDiagnostic Microbiology and Infectious Disease, 1999
- Glycopeptide resistance in staphylococciCurrent Opinion in Infectious Diseases, 1998
- The specter of glycopeptide resistance: current trends and future considerationsThe American Journal of Medicine, 1998
- Vancomycin‐Resistant EnterococciClinical Infectious Diseases, 1998
- Methicillin and glycopeptide resistance in staphylococci: a new threat?Current Opinion in Infectious Diseases, 1995
- Emergence of Vancomycin Resistance in Coagulase-Negative StaphylococciNew England Journal of Medicine, 1987
- TEICOPLANIN-RESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCUSThe Lancet, 1986